VP Service Solutions - PET Imaging & Radiopharmacy Infrastructure
About the job
- A bachelor's degree in Healthcare Administration, Radiological Sciences, or a related field.
- A master's degree in Business Administration or Healthcare Management.
- At least 10–15 years of progressive leadership experience in medical imaging, radiopharmacy, or healthcare infrastructure development.
- A proven track record managing complex, multi-site projects, including PET/CT installations or nuclear medicine.
- Strong financial acumen, including budgeting, forecasting, and contract management.
- Demonstrated ability to lead cross-functional teams and manage third-party vendors.
- Ability to drive innovation while maintaining operational and regulatory rigor.
- Define and execute the service strategy for PET scanner solutions, radiopharmacy buildouts, and imaging center service offerings in alignment with corporate growth objectives.
- Oversee the end-to-end design, construction, and commissioning of PET scanner installations and radiopharmacy facilities, ensuring compliance with FDA, NRC, and state health regulations.
- Build scalable service delivery frameworks, including vendor management, logistics, quality assurance, and maintenance programs, to ensure timely, cost-effective, and high-quality execution.
- Lead executive-level engagement with hospitals, imaging centers, and private investors to develop customized service models and long-term partnerships.
- Develop P&L ownership for the Service Solutions division; establish revenue targets, pricing structures, and margin optimization strategies.
- Ensure all solutions meet applicable standards for radiopharmaceutical handling, radiation safety, facility design, and medical equipment operation.
- Build and manage a multidisciplinary team of engineers, project managers, and service professionals to deliver client outcomes.
- Identify emerging technologies, service models, and partnership opportunities to expand the organization’s footprint in molecular imaging and diagnostic infrastructure.
About the company
Telix Pharmaceuticals develops and commercializes diagnostic and therapeutic products that use targeted radiation to diagnose and treat cancer and rare diseases. Its pipeline covers urologic oncology (prostate and kidney cancers), neuro-oncology (glioma), musculoskeletal oncology (sarcoma), and bone marrow conditioning. The treatments work by delivering targeted radiation to diseased tissues, enabling more precise decisions for treatment and allowing for personalized therapy. The company differentiates itself through a global, robust supply chain and a focus on integrating diagnostic and therapeutic options to address unmet medical needs, along with strong commitments to patient care, ethical practices, and environmental responsibility. Telix’s goal is to improve quality of life and outcomes for patients by providing targeted, clinically meaningful diagnostic and therapeutic solutions that support better treatment decisions and personalized care.
Company Size
1,001-5,000
Company Stage
IPO
Headquarters
Melbourne, Australia
Founded
2015
Get referred to Telix Pharmaceuticals
See people who can refer or advise you
Simplify's Take
What believers are saying
- FDA approved Pixclara on September 13, 2026, opening Telix's first brain-cancer imaging market.
- H1 2026 revenue reached $477 million, up 22%, with EBITDA rising 146%.
- BiPASS enrolled 350 patients and Telix aligned with FDA on a U.S. NDA pathway.
What critics are saying
- Telix still depends on FDA manufacturing acceptance for Zircaix resubmission in 2026.
- The $2.35 billion ITM deal brings dilution, debt, and integration strain through 2027.
- Novartis, with Lutathera and Pluvicto, attacks Telix in GEP-NETs and prostate therapy.
What makes Telix Pharmaceuticals unique
- Telix sells both diagnostics and therapies across the same radiopharmaceutical platform.
- Illuccix and Gozellix give Telix a commercial prostate imaging franchise in 24 countries.
- ITM adds isotope manufacturing, distribution, and lutetium-177 supply across more than 65 countries.
Help us improve and share your feedback! Did you find this helpful?
Benefits
- Annual Performance Bonus
- Equity-Based Incentive Program
- Paid Vacation
- Paid Wellness Days
- Hybrid Work Options
- Remote Work Options